SUMMARY Chromosome and enzyme determinations were performed in 250 pregnancies between the 7th and the 12th week of gestation. The majority of the tests were performed for risk of chromosomal abnormalities and 75% of the women were 35 years old or more. We describe a chorionic villi sampling (CVS) technique which proved to be highly efficient, with a diagnostic success rate of 97-7%. In the light of our experience we suggest that CVS is best performed between the 9th and 10th weeks of pregnancy. The average weight of the aspirated specimen was 20 mg with a lower limit of 5 mg which proved sufficient for diagnostic purposes 
The methods for fetal diagnosis of genetic disorders in the second trimester of pregnancy are reliable and relatively safe and are an integral part of antenatal care. However, the obstetrical complications and the psychological constraint of selective abortion at around the 20th week of gestation are disadvantages that could be reduced by performing diagnosis in the first trimester. 1-3 'The Scandinavian trials4 5 first demonstrated the possibility of chorionic villi sampling (CVS), but an anonymous report from China was, until recently, the only clinical experience of first trimester fetal diagnosis.6 In an experimental study comparing four different sampling methods on a series of women scheduled for voluntary abortion we demonstrated that ultrasound guided villi aspiration is safe and efficient.7 It was therefore possible to introduce this sampling technique as a new antenatal diagnostic approach for fetal karyotyping and enzymatic tests.
In this paper we report the clinical evaluation of Vaginal swabs for bacteriology four days before CVS and immediately before sampling were negative in 29 out of 100 cases. In the remaining 221 cases in which intravaginal treatment preceded CVS, 75 (34%) had positive cervical cultures, Streptococcus, Enterobacter, Candida albicans, and Gardnerella vaginalis being the most frequently found. In two of the nine fetal losses (cases 8 and 54) The average time interval between CVS and laboratory diagnosis was three days, ranging from three hours to seven days. Fetal chromosome studies were successful in 247 out of 248 cases in which villi were obtained at sampling. The diagnostic failure occurred where the sample was good but the metaphases were of poor quality. As shown in table 1, an abnormal chromosome constitution was found in 21 cases. Of these, 16 were aneuploid, three were Robertsonian translocations, one was a balanced insertion inherited from the father, and one was an inv(X) in a male fetus. Two trisomies were found in female fetuses from pregnancies at risk for X linked disorders. The cytogenetic analysis confirmed the diagnosis in 14 out of 16 cases with abnormal karyotypes in which a selective abortion was performed. The abnormal chromosome constitution was also confirmed in the case with monosomy X, in which intrauterine death of the fetus occurred one week after sampling.
In two cases the abnormal fetal karyotype detected by the direct method was not confirmed after termination of the pregnancy. These were a mosaic with trisomy 3 and a trisomy 16 The overall success rate of more than 96% confirmed the expectation derived from the experimental study.7 The few sampling failures were due to some specific conditions for which the sampling technique should be considered inadequate. These were mainly the following: (a) the placental tissue is hardly outlined before the eighth week; (b) the implantation site was too far (more than 16 cm) from the vaginal entrance, mainly observed from the 11th week onwards; and (c) the angle between the cervical axis and the intrauterine path to the placenta was unusually pronounced.
A longer catheter could allow a successful sampling in condition (b), as could the use of a rigid device or transabdominal aspiration in condition (c).
In any case, to reduce the inconvenience of unsuccessful introduction of the catheter it seems appropriate to limit the sampling to the ninth and tenth weeks and to perform CVS later in the pregnancy only after an accurate evaluation by the combined use of ultrasound and the hysterometer. In the present experience 78% of samples were taken from nine to ten weeks, while the number of cases sampled between the seventh and eighth week was small (10%) and confined to the beginning of the study. Recently, a limited number of selected cases (12%) was delayed and sampled at 11 and 12 weeks because of growing demand and limited diagnostic resources. With increasing experience the umbilical cord insertion to the placenta was identified in more than 90% of the cases and introduced as a specific indicator of the sampling site. Although in the last 104 cases the overall success rate by these new sampling criteria remained nearly unchanged (table  3) , the number of cases in which more than one aspiration attempt was necessary to obtain chorionic villi was reduced from 38% to 14%.
The aspiration procedure gave consistent amounts of chorionic tissue sufficient for all diagnostic purposes. In only three cases a second specimen was requested during the same procedure to set up long term culture of chorionic villi cells.
FETAL LOSS AND OBSTETRIC COMPLICATIONS
A crude fetal loss rate of 3-9% could be estimated including the 125 cases still in progress at the time of writing, 72 of which are over 20 weeks' gestation. However, the follow up to term of the first 100 cases provided a correct rate of 7%. No case of fetal loss was observed within seven days of sampling. A direct relationship between the sampling procedure and the abortion was postulated in cases 75 and 195. In case 75, bleeding and uterine contractions started on the third day and a complete abortion took place on the tenth day. The patient complained of suprapubic pains during the two weeks preceding CVS. The fever present in case 195 at the same time as vaginal bleeding and uterine contractions was suspected to be the consequence of bacterial invasion of the uterine cavity following CVS, although the cervical culture at sampling was negative and only one uncomplicated aspiration was made. In cases 54 and 144 the fetal death detected at the scheduled ultrasound check one week after CVS strongly suggested a relationship with the chromosomal abnormalities found in the fetus. In the other seven cases there was no evidence of injury at the time of CVS, such as haemorrhage or membrane perforation, or post mortem evidence of damage to the placenta. Although no obvious connection could be established between the fetal loss and the number of times the catheter was introduced, in three of the first four fetal losses the catheter insertion was repeated four times. Thus, we decided to limit the aspiration attempts to a maximum of two to minimise placental trauma and the likelihood of bacterial invasion. The gestational age at sampling and the total amount of chorionic villi aspirated were apparently not related to the abortion rate. It should be noted that all six chromosomally normal fetuses lost after CVS were female.
No direct perforation of the ovular sac was detected soon after sampling. The amniotic fluid leakage in cases 16 , 65, and 102 should be interpreted as a late sign of threatened abortion rather than as a direct consequence of the procedure. In all three cases villi were sampled at the first attempt, and the procedure reviewed on videotape did not show threatening movements of the tip of the catheter. Nevertheless, some direct undetectable trauma reducing the resistance of the chorion and favouring a spontaneous rupture cannot be excluded, nor can the concurrence of an intrauterine infection.
The slight or moderate bleeding which occurred in several cases during the first two days had no adverse effect and should be considered as a harmless consequence of placental perforation during the aspiration of chorionic tissue.
Considering the clinical and ultrasound evidence for the 93 cases which came to term and for the remaining cases still in progress, no adverse findings were observed in the mother or the fetus which could be attributed to the CVS procedure.
Two further aspects of first trimester fetal diagnosis should be evaluated during the current applied research phase, namely the fetomaternal haemorrhage and the intrauterine infections as a consequence of the aspiration procedure.
FETOMATERNAL HAEMORRHAGE
Fetomaternal transfusion was postulated as a possible consequence of the CVS and was checked by the variation of AFP levels in maternal serum samples taken before and after sampling. The preliminary analysis of the data seems to indicate a significant change in the maternal serum AFP after CVS in a large proportion of cases. In over 50% where more than 50 mg of chorionic villi were aspirated a significant rise in maternal AFP level was demonstrated. In the Rhesus negative mothers at risk of Rh isoimmunisation and without antibodies, anti-D immunoglobulins were administered to avoid immunisation. To date, the follow up of the fetuses and infants of the 16 patients treated with 200 tg anti-D immunoglobulin after CVS is in progress and no developmental problems have been seen which could be related to anti-D serum prophylaxis.
However, the anti-A antibodies which appeared late in the pregnancy in the three women at risk for ABO incompatibility could be a consequence of fetomaternal transfusion following chorionic villi aspiration, although in these cases no significant differences in maternal AFP levels before and after sampling were detectable.
INTRAUTERINE INFECTIONS
Although our data suggest that there is only a very limited risk of acute intrauterine infection following CVS, bacterial invasion of the uterine cavity may play an aetiological role in the later complications of pregnancy, such as preterm rupture of membranes or fetal death in utero.'345 No clinical signs were observed in the nine patients with fetal loss, and the bacteriological study undertaken in four of them on the fetus or membranes or both was inconclusive. The high rate (36%) of positive cultures of cervical swabs just before CVS and after antimicro-bial prophylaxis highlights the low efficacy of the vaginal treatment. In this connection, we lack comprehensive knowledge of the ecology and significance of the vaginal flora and of the effect of antibiotics on it. At the same time we need knowledge on the teratogenic or toxic effect on the fetus of a series of antimicrobial substances that are or could be used for vaginal treatment.
CONTRAINDICATIONS
The presence of Rh immunisation should be considered as an absolute contraindication to CVS: the fetal blood frequently detected in the maternal stream could be sufficient to (4) The proportion of fetal losses, which is estimated at the time of writing as 4 to 7%, is in the range of the spontaneous abortion rate expected for pregnancies between the second and third month of gestation.21
The risk of diagnostic errors appears to be very low. Nevertheless, the occurrence of two discrepancies between placental cells and fetal fibroblasts emphasises the need for more data in order to evaluate the incidence of this phenomenon and its clinical significance.
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